News Agencies Feed

healthcare

Aug 14

Dubai Health Authority Implements Masimo Patient SafetyNet™

Dubai Health Authority Implements Masimo Patient SafetyNet™

(ME NewsWire)-- Masimo (NASDAQ:MASI) announced today that the Dubai Health Authority (DHA), the government organization that oversees the healthcare systems of Dubai, is augmenting its current inventory of Masimo equipment and technology with the implementation of Masimo Patient SafetyNet™*, a supplemental remote monitoring and clinician notification system, at two hospitals in Dubai. Masimo Patient SafetyNet enables information from bedside monitors, such as Masimo Root® with the Radical-7® or wearable Radius-7® Pulse CO-Oximeter®, to be accessible from a central viewing station. When changes occur in measured values,......

Continue Reading >>

Aug 10

Gulf Inject partners with Zulekha Healthcare Group

Gulf Inject partners with Zulekha Healthcare Group

Gulf Inject, a Julphar company - the region’s leading pharmaceutical manufacturer, has announced it has signed a local distribution agreement with Zulekha Healthcare Group.

The business milestone event was"...

Continue Reading >>

Aug 10

FDA Allows WIN Consortium to Proceed with Targeted Tri-Therapy Clinical Trial in First Line Treatment of Metastatic Non Small Cell Lung Cancer

FDA Allows WIN Consortium to Proceed with Targeted Tri-Therapy Clinical Trial in First Line Treatment of Metastatic Non Small Cell Lung Cancer

(ME NewsWire)-- WIN Consortium (WIN) received the US Food and Drug Administration (FDA)’s approval to start the clinical investigation of a novel therapeutic approach using a combination of three targeted therapies for the first line treatment"...

Continue Reading >>

Aug 07

Study Evaluates Performance of Masimo SpHb® in Trauma Patients with Low Hemoglobin Levels

Study Evaluates Performance of Masimo SpHb® in Trauma Patients with Low Hemoglobin Levels

[ AETOS Wire ] -- Masimo (NASDAQ: MASI) announced today the findings of a recently published study in which researchers at Cairo University in Egypt evaluated the performance of Masimo SpHb®, noninvasive, continuous hemoglobin measurement, in trauma patients with low hemoglobin levels.1 In the prospective, observational study, Dr. Gamal and colleagues sought to evaluate SpHb measurements on trauma patients with low hemoglobin levels (below 8 g/dL) because trauma patients are “vulnerable to frequent blood transfusion.” They enrolled 70 adult patients with hemoglobin levels lower than 8 g/dL who were admitted to the emergency department......

Continue Reading >>

Aug 02

Graminex L.L.C. Receives NNHPD Health Canada Approval for PollenAid® and Prostanex®

Graminex L.L.C. Receives NNHPD Health Canada Approval for PollenAid® and Prostanex®

Graminex® LLC, producer of Graminex® Flower Pollen Extracts™, receives Health Canada Approval under the Natural and Non-prescription Health Products Directorate (NNHPD) for its PollenAid® and Prostanex® Flower Pollen Extract™ formulations.

Health"...

Continue Reading >>

Aug 02

Salvia on the rise in Lebanon, experts sound the alarm

Adolescents in Lebanon are increasingly seeking the psychedelic properties of a mind-altering drug, Salvia Divinorum, believed to be the most potent naturally occurring hallucinogen. Commonly known as a sacred spiritual plant native of the mountains of Mexico, Salvia has spread on the international"...

Continue Reading >>

Aug 01

Study Compares Performance of Masimo Acoustic Respiration Rate (RRa®) and Nellcor Plethysmographic Respiration Rate in Volunteers 

Study Compares Performance of Masimo Acoustic Respiration Rate (RRa®) and Nellcor Plethysmographic Respiration Rate in Volunteers 

(ME NewsWire)-- Masimo (NASDAQ: MASI) announced today that researchers at the Tokyo Women’s Medical University, Department of Anesthesiology, in Japan have published a study investigating the measurement of respiration rate in volunteers. Masimo acoustic respiration rate (Masimo), using the Masimo Radical-7® Pulse CO-Oximeter®, was studied alongside Nellcor plethysmographic respiration rate (Nellcor), using the Nellcor PM1000N.1 Dr. Kitsiripant and colleagues enrolled 50 healthy adult volunteers in the study. Respiration rate, pulse rate, and oxygen saturation (SpO2) values were measured using the two technologies: Nellcor respiration......

Continue Reading >>

Aug 01

Saudi Arabia distributes bread to 86,000 Syrian families in Lebanon, Syria

The Saudi National Campaign to support Syrian refugees has continued distributing bread to displaced Syrians in Lebanon and northern Syria through its mobile bakeries, the Saudi Press Agency (SPA) said.
In the 196th week of operations inside Syria, the mobile bakeries produced 1.272"...

Continue Reading >>

Jul 29

Takeda Reports 1st Quarter FY2017 Results

Takeda Reports 1st Quarter FY2017 Results

(ME NewsWire)-- Takeda Pharmaceutical Company Limited (TOKYO:4502): Underlying Revenue growth of 6.6% led by Takeda's Growth Drivers Underlying Revenue grew +6.6% with growth across all regions (U.S. +13.5%, Japan +1.6%, Europe & Canada +4.6%, Emerging Markets +6.0%). Takeda's Growth Drivers (GI, Oncology, CNS and Emerging Markets) maintained their strong momentum to deliver growth of +14.7%. GI (Gastroenterology) +23.2%, led by continued success of ENTYVIO® and TAKECAB® Oncology +12.2%, driven by NINLARO®,......

Continue Reading >>

Jul 27

Boehringer Ingelheim starts clinical study on interchangeability between its adalimumab biosimilar candidate and HUMIRA® 

Boehringer Ingelheim starts clinical study on interchangeability between its adalimumab biosimilar candidate and HUMIRA® 

  • First patient enrolled into VOLTAIRE-X; an interchangeability study designed to assess whether BI 695501 is interchangeable with Humira®1
  • First study in the U.S. to investigate an interchangeability designation for an adalimumab biosimilar candidate
  • BI 695501 is currently under review by regulatory authorities2

...

Continue Reading >>